Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods
- Weitere Titel
-
Die Vorhersage von triple-negativem Brustkrebs mithilfe von brustkrebsassoziierten Einzelnukleotid-Polymorphismen und verschiedenen Variablenselektionsmethoden
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods ; volume:77 ; number:06 ; year:2017 ; pages:667-678
Geburtshilfe und Frauenheilkunde ; 77, Heft 06 (2017), 667-678
- Beteiligte Personen und Organisationen
-
Häberle, Lothar
Hein, Alexander
Rübner, Matthias
Schneider, Michael
Ekici, Arif Bülent
Gass, Paul
Hartmann, Arndt
Schulz-Wendtland, Rüdiger
Beckmann, Matthias W.
Lo, Wing-Yee
Schroth, Werner
Brauch, Hiltrud
Fasching, Peter Andreas
Wunderle, Marius
- DOI
-
10.1055/s-0043-111602
- URN
-
urn:nbn:de:101:1-2018102912574303183844
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Häberle, Lothar
- Hein, Alexander
- Rübner, Matthias
- Schneider, Michael
- Ekici, Arif Bülent
- Gass, Paul
- Hartmann, Arndt
- Schulz-Wendtland, Rüdiger
- Beckmann, Matthias W.
- Lo, Wing-Yee
- Schroth, Werner
- Brauch, Hiltrud
- Fasching, Peter Andreas
- Wunderle, Marius
Ähnliche Objekte (12)
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
Metastatic Triple-Negative Breast Cancer
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
Metastatic Triple-Negative Breast Cancer
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
Metastatic Triple-Negative Breast Cancer
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study